IRIS - Res&Arch Institutional Research Information System - Research & Archive

PALLOTTA, MARIA TERESA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.708
EU - Europa 1.529
AS - Asia 723
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 1
Totale 3.973
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.704
IT - Italia 493
IE - Irlanda 276
SG - Singapore 228
HK - Hong Kong 195
VN - Vietnam 167
FR - Francia 155
RO - Romania 155
CN - Cina 103
DE - Germania 94
UA - Ucraina 80
SE - Svezia 52
FI - Finlandia 50
RU - Federazione Russa 40
BE - Belgio 38
GB - Regno Unito 34
CZ - Repubblica Ceca 31
CH - Svizzera 12
TR - Turchia 11
KR - Corea 9
CI - Costa d'Avorio 7
GR - Grecia 6
NL - Olanda 5
EU - Europa 4
AT - Austria 3
LB - Libano 3
CA - Canada 2
IL - Israele 2
MK - Macedonia 2
MX - Messico 2
PL - Polonia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BR - Brasile 1
HU - Ungheria 1
IN - India 1
JP - Giappone 1
QA - Qatar 1
Totale 3.973
Salva come PNG Salva come JPEG
Città #
Chandler 323
Perugia 285
Dublin 276
Hong Kong 194
Singapore 193
Dong Ket 167
Bucharest 155
San Mateo 136
Boardman 120
Santa Clara 82
Redmond 77
Wilmington 66
Medford 57
Princeton 56
Altamura 55
Ann Arbor 54
Beijing 48
Lawrence 42
Brussels 38
Andover 37
Jacksonville 35
Des Moines 27
Pisa 26
Ashburn 24
Falls Church 20
Dearborn 18
Los Angeles 17
Redwood City 17
Olomouc 16
Saint Petersburg 16
Brno 15
Helsinki 14
West Jordan 14
Munich 13
Dallas 12
Fremont 12
Norwalk 12
San Paolo di Civitate 12
Enfield 11
Izmir 10
Terni 9
Woodbridge 9
Seoul 8
Abidjan 7
Chicago 6
Rome 6
San Diego 6
Hanover 5
Nürnberg 5
Houston 4
Moscow 4
Paris 4
Auburn Hills 3
Cassino 3
Civitanova Marche 3
Den Haag 3
Frankfurt am Main 3
Guangzhou 3
Nanjing 3
Nichelino 3
Assisi 2
Bologna 2
Boydton 2
Castel Maggiore 2
Collazzone 2
Esslingen am Neckar 2
Fairfield 2
Gunzenhausen 2
Jerusalem 2
Kunming 2
Lappeenranta 2
Ludwigshafen 2
L’Aquila 2
Macerata 2
Milan 2
Nea Smyrni 2
Ningbo 2
Parma 2
Planegg 2
Saint Louis 2
San Jose 2
Santarcangelo di Romagna 2
Silea 2
Spoleto 2
Vicenza 2
Alghero 1
Amsterdam 1
Athens 1
Azcapotzalco 1
Budapest 1
Buffalo 1
Cardiff 1
Carrollton 1
Chengdu 1
Düsseldorf 1
Edinburgh 1
Elk Grove Village 1
Espoo 1
Falkenstein 1
Foshan 1
Totale 2.964
Salva come PNG Salva come JPEG
Nome #
Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1 174
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 138
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 130
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 127
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 124
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 122
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 118
Amino-acid sensing and degrading pathways in immune regulation 116
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 109
Amino acid metabolism as drug target in autoimmune diseases 104
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry 101
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 91
LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism 89
The TGF-β/IDO axis in infectious tolerance. 88
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 86
87P - Towards the identification of the mechanism of action of antitumor 1-methyl-D-tryptophan 86
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 84
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 84
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 83
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 78
88P - Relationship between functions and intracellular localization of the immune checkpoint target indoleamine 2, 3-dioxygenase 1 77
Different partners, opposite outcomes: A New Perspective of the Immunobiology of Indoleamine 2,3-Dioxygenase 73
AhR-Mediated, Non-Genomic Modulation of IDO1 Function 70
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 66
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 66
Amino acid metabolism in rheumatoid arthritis: Friend or foe? 65
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 64
Novel mutations in the WFS1 gene are associated with Wolfram syndrome and systemic inflammation 59
Reinstalling immune regulatory tryptophan catabolism in juvenile diabetes via interleukin 6 receptor blockade 57
Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. 56
CTLA-4-immunoglobulin and indoleamine 2,3 dioxygenase in dominant tolerance. 55
Ectopic expression of IL-35Ig by dendritic cells induces IDO-related tolerance in vivo 55
Pharmacologic Induction of Endotoxin Tolerance in Dendritic Cells by L-Kynurenine 55
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity 54
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 53
Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine 53
Topical application of soluble CD83 induces IDO-mediated immune modulation, increases foxp3+ T cells, and prolongs allogeneic corneal graft survival 50
IDO1 and TGF-β mediate protective effects of IFN-α in antigen-induced arthritis 50
Wolfram syndrome, a rare neurodegenerative disease: From pathogenesis to future treatment perspectives 48
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 47
Unconventional Transport Routes of Soluble and Membrane Proteins and Their Role in Developmental Biology 46
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls 46
Unconventional Pathways of Protein Secretion: Mammals vs. Plants 45
Proteasomal Degradation of Indoleamine 2,3-Dioxygenase in CD8 Dendritic Cells is Mediated by Suppressor of Cytokine Signaling 3 (SOCS3). 45
Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients 45
Endotoxin tolerance as a novel defense strategy in infectious diseases: the role of tryptophan catabolism 44
The [1,2,4]Triazolo[4,3-a]pyridine as a New Player in the Field of IDO1 Catalytic Holo-Inhibitors 44
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 40
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 39
Extracellular Vesicles in Aging: An Emerging Hallmark? 38
Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 38
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma 37
Moonlighting Proteins Are Important Players in Cancer Immunology 36
Vedere per credere: utilizzo della microscopia per lo studio dell’immunologia 35
Western blot identification of NPM1 leukemic mutants in cytological AML samples: A powerful diagnostic technique 34
Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity 34
FGF2 and IL-1β - explorers of unconventional secretory pathways at a glance 30
PROTEASOME INHIBITION IN pDCs CONFERS AN IDO-DEPENDENT IMMUNOREGULATORY PHENOTYPE 28
Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme 27
IDO-TARGETING INTERVENTION IN AUTOIMMUNE DIABETES BY PROTEASOME INHIBITION 27
Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 24
Indoleamine 2,3 dioxygnenase: as an inducer and amplifier of regulatory T cell functions. 23
Human Indoleamine 2,3-dioxygenase 1 (IDO1) Expressed in Plant Cells Induces Kynurenine Production 21
Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function 20
The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1 19
GLP-1 receptor agonists as promising disease-modifying agents in WFS1 spectrum disorder 15
Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells 15
Sensing of an HIV-1-Derived Single-Stranded RNA-Oligonucleotide Induces Arginase 1-Mediated Tolerance 12
Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1 1
Totale 4.213
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.597
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.597
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020257 0 0 0 0 34 29 32 25 48 47 19 23
2020/2021534 5 14 4 20 156 22 40 20 40 23 18 172
2021/2022848 6 103 15 18 27 17 6 148 101 116 93 198
2022/20231.109 60 190 16 83 101 99 2 62 383 14 87 12
2023/2024605 26 69 21 13 8 11 158 18 42 35 65 139
2024/2025397 21 97 56 106 117 0 0 0 0 0 0 0
Totale 4.213